These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acquired coagulation inhibitor in association with Rocky Mountain spotted fever. With a review of other acquired coagulation inhibitors. Scimeca PG; Weinblatt ME; Kochen JA Clin Pediatr (Phila); 1987 Sep; 26(9):459-63. PubMed ID: 3621770 [TBL] [Abstract][Full Text] [Related]
24. [New results in Rocky Mountain spotted fever and toxoplasmosis in the Central Congo]. GIROUD P; JADIN J; REIZES C Bull Soc Pathol Exot Filiales; 1951; 44(7-8):422-4. PubMed ID: 14905189 [No Abstract] [Full Text] [Related]
25. Nodal tachycardia in a case of Rocky Mountain spotted fever. AQUILINA JT; ROSENBERG F; WUERTZ RL Am Heart J; 1952 May; 43(5):755-60. PubMed ID: 14923618 [No Abstract] [Full Text] [Related]
26. Neurologic sequelae of Rocky Mountain spotted fever. BERLIN L; THOMAS MH Univ Hosp Bull; 1948 Mar; 14(3):22. PubMed ID: 18915001 [No Abstract] [Full Text] [Related]
27. Skeletal muscle involvement in Rocky Mountain spotted fever. Krober MS South Med J; 1978 Dec; 71(12):1575-6. PubMed ID: 725640 [TBL] [Abstract][Full Text] [Related]
33. Possible coagulation defects seen in Rocky Mountain spotted fever. Driggers DA Med Ann Dist Columbia; 1974 Jan; 43(1):25-8. PubMed ID: 4521176 [No Abstract] [Full Text] [Related]